People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

An experimental treatment for depression that triggers seizures with magnets significantly improved mental health in patients ...

Mumbai (Maharashtra) [India], January 16: Schneider Electric, the leader in the digital transformation of energy management and automation, announced that it has been awarded the contract to automate ...

Schneider Electric has secured a contract to automate India's largest water treatment plant in Bhandup, Mumbai. This project aligns with the Maharashtra government's mission to provide potable water ...

“I really wasn’t expecting that. I’m just in shock right now,” Moore said when she took the stage. “I’ve been doing this a long time, like over 45 years, and this is the first time I ...